Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status - PubMed (original) (raw)
Comparative Study
Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status
M C Bibby et al. Br J Cancer. 1991 Jan.
Free PMC article
Abstract
Flavone acetic acid (FAA) is a synthetic flavonoid with dramatic pre-clinical anti-tumour activity involving a vascular component in its mechanism but no clinical effects have been seen to date. As FAA also has immunomodulatory activity, immunological factors might explain differences in activity between mouse and man. This study examines the influence of host immune status on the anti-tumour activity of FAA. Two human colon tumour xenografts (COBA, HT-29) fail to respond to FAA in nude mice. The lack of activity of FAA against HT-29 xenografts cannot be explained on the basis of limited drug bioavailability as achievable plasma, and tumour levels of FAA are similar to those seen in sensitive murine colon tumours. The immune status of the host also influences the activity of FAA against two transplantable tumours of the mouse colon. Both these tumours are highly responsive to FAA in their normal NMRI hosts, but neither tumours exhibited significant growth delay in thymectomised NMRI or nude hosts. Histological examination of treated tumours revealed significant areas of haemorrhagic necrosis in all three hosts. These data suggest a clear immunological component in the mechanism of action of FAA which is separate from the previously described haemorrhagic necrosis.
Similar articles
- Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512).
Bibby MC, Phillips RM, Double JA. Bibby MC, et al. Cancer Chemother Pharmacol. 1989;24(2):87-94. doi: 10.1007/BF00263126. Cancer Chemother Pharmacol. 1989. PMID: 2731316 - The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours.
Bibby MC, Phillips RM, Double JA. Bibby MC, et al. Br J Cancer. 1991 Apr;63(4):541-5. doi: 10.1038/bjc.1991.127. Br J Cancer. 1991. PMID: 2021538 Free PMC article. - Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).
Bibby MC, Double JA, Loadman PM. Bibby MC, et al. Br J Cancer. 1988 Sep;58(3):341-4. doi: 10.1038/bjc.1988.215. Br J Cancer. 1988. PMID: 3179187 Free PMC article. - Flavone acetic acid--from laboratory to clinic and back.
Bibby MC, Double JA. Bibby MC, et al. Anticancer Drugs. 1993 Feb;4(1):3-17. doi: 10.1097/00001813-199302000-00001. Anticancer Drugs. 1993. PMID: 8457711 Review. - Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent.
O'Dwyer PJ, Shoemaker D, Zaharko DS, Grieshaber C, Plowman J, Corbett T, Valeriote F, King SA, Cradock J, Hoth DF, et al. O'Dwyer PJ, et al. Cancer Chemother Pharmacol. 1987;19(1):6-10. doi: 10.1007/BF00296246. Cancer Chemother Pharmacol. 1987. PMID: 3545524 Review.
Cited by
- Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.
Garland KM, Sheehy TL, Wilson JT. Garland KM, et al. Chem Rev. 2022 Mar 23;122(6):5977-6039. doi: 10.1021/acs.chemrev.1c00750. Epub 2022 Feb 2. Chem Rev. 2022. PMID: 35107989 Free PMC article. Review. - Nanodelivery of STING agonists against cancer and infectious diseases.
Zhou J, Ventura CJ, Fang RH, Zhang L. Zhou J, et al. Mol Aspects Med. 2022 Feb;83:101007. doi: 10.1016/j.mam.2021.101007. Epub 2021 Aug 2. Mol Aspects Med. 2022. PMID: 34353637 Free PMC article. Review. - Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
Zheng J, Mo J, Zhu T, Zhuo W, Yi Y, Hu S, Yin J, Zhang W, Zhou H, Liu Z. Zheng J, et al. Mol Cancer. 2020 Aug 27;19(1):133. doi: 10.1186/s12943-020-01250-1. Mol Cancer. 2020. PMID: 32854711 Free PMC article. Review. - Anticancer flavonoids are mouse-selective STING agonists.
Kim S, Li L, Maliga Z, Yin Q, Wu H, Mitchison TJ. Kim S, et al. ACS Chem Biol. 2013 Jul 19;8(7):1396-401. doi: 10.1021/cb400264n. Epub 2013 May 23. ACS Chem Biol. 2013. PMID: 23683494 Free PMC article. - Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Tijono SM, Guo K, Henare K, Palmer BD, Wang LC, Albelda SM, Ching LM. Tijono SM, et al. Br J Cancer. 2013 Apr 2;108(6):1306-15. doi: 10.1038/bjc.2013.101. Epub 2013 Mar 12. Br J Cancer. 2013. PMID: 23481185 Free PMC article.
References
- Br J Cancer. 1973 May;27(5):370-89 - PubMed
- Eur J Cancer Clin Oncol. 1989 Oct;25(10):1419-24 - PubMed
- Br J Cancer. 1976 Mar;33(3):241-59 - PubMed
- Cancer Treat Rep. 1986 May;70(5):631-5 - PubMed
- Br J Cancer. 1986 Oct;54(4):595-600 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous